Can you lower ApoB with diet?

Yes, you can lower ApoB through dietary changes like reducing saturated fats, increasing fiber, and following Mediterranean or plant-based diets. Studies show diet modifications can reduce ApoB by 10-30%, though some individuals may need additional interventions.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding ApoB and Its Role in Heart Health

Apolipoprotein B (ApoB) is a protein found on the surface of atherogenic lipoproteins, including LDL (low-density lipoprotein), VLDL (very low-density lipoprotein), and Lp(a). Each of these particles contains exactly one ApoB molecule, making ApoB a direct measure of the number of potentially harmful cholesterol-carrying particles in your blood.

Unlike traditional cholesterol tests that measure the amount of cholesterol within particles, ApoB counts the actual number of particles. This distinction is crucial because research shows that particle number, not cholesterol content, drives atherosclerosis and cardiovascular disease risk. Even if your LDL cholesterol appears normal, elevated ApoB levels indicate a higher number of atherogenic particles that can penetrate arterial walls and cause plaque buildup.

The good news is that ApoB levels are modifiable through lifestyle interventions, particularly diet. Understanding how different foods and eating patterns affect ApoB can empower you to make targeted changes that significantly reduce your cardiovascular risk. Regular monitoring through comprehensive testing helps track your progress and optimize your approach.

Dietary Approaches and Their Impact on ApoB Levels

Diet TypeAverage ApoB ReductionKey FoodsTime to Effect
MediterraneanMediterranean Diet10-15%Olive oil, fish, nuts, whole grains2-3 months
PortfolioPortfolio Diet20-24%Soy, nuts, plant sterols, viscous fiber1-3 months
Plant-BasedPlant-Based15-20%Legumes, vegetables, whole grains, nuts2-3 months
DASHDASH Diet8-12%Fruits, vegetables, low-fat dairy, lean protein2-3 months
Low-CarbLow-Carb (Quality Fats)Variable (-5 to +10%)Avocados, nuts, olive oil, fish1-2 months

Individual responses vary based on genetics, baseline ApoB levels, and dietary adherence.

How Diet Impacts ApoB Levels

Diet influences ApoB levels through multiple mechanisms. The foods you eat affect how your liver produces and clears atherogenic particles, the composition of these particles, and the overall inflammatory state of your body. Understanding these mechanisms helps explain why certain dietary approaches are particularly effective at lowering ApoB.

Saturated Fat and ApoB Production

Saturated fats, found primarily in animal products and tropical oils, stimulate the liver to produce more ApoB-containing particles. When you consume saturated fat, your liver packages it into VLDL particles for transport throughout the body. Each VLDL particle contains one ApoB molecule, so increased VLDL production directly raises ApoB levels. Additionally, saturated fats can reduce the activity of LDL receptors on liver cells, impairing the clearance of ApoB particles from circulation.

Fiber's Protective Effects

Soluble fiber acts as a powerful ApoB-lowering agent through several mechanisms. In the digestive tract, soluble fiber binds to bile acids, preventing their reabsorption. Since bile acids are made from cholesterol, your liver must pull more cholesterol from the blood to produce new bile acids, reducing the substrate available for VLDL production. Fiber also slows digestion and glucose absorption, reducing insulin spikes that can stimulate ApoB particle production.

The Role of Dietary Cholesterol

While dietary cholesterol's impact on ApoB is generally less significant than saturated fat, individual responses vary considerably. Some people, termed 'hyper-responders,' experience substantial increases in ApoB when consuming high-cholesterol foods. This variability is partly genetic, influenced by variations in genes controlling cholesterol absorption and metabolism. For most people, limiting dietary cholesterol to less than 300mg per day supports optimal ApoB levels.

Evidence-Based Dietary Strategies to Lower ApoB

Research has identified several dietary patterns and specific interventions that effectively reduce ApoB levels. These approaches vary in their mechanisms and magnitude of effect, allowing you to choose strategies that align with your preferences and lifestyle.

The Mediterranean Diet Advantage

The Mediterranean diet consistently demonstrates impressive ApoB-lowering effects. A landmark study published in the New England Journal of Medicine found that following a Mediterranean diet supplemented with extra virgin olive oil or nuts reduced cardiovascular events by 30% compared to a low-fat diet. Participants on the Mediterranean diet showed significant reductions in ApoB levels, averaging 10-15% decreases within 3 months.

This eating pattern emphasizes whole grains, legumes, fruits, vegetables, fish, and olive oil while limiting red meat and processed foods. The high content of monounsaturated fats from olive oil and nuts helps improve the clearance of ApoB particles, while the abundant fiber and phytonutrients provide additional cardiovascular protection.

Plant-Based Approaches

Plant-based diets offer some of the most dramatic ApoB reductions. The Portfolio Diet, which combines plant sterols, soy protein, viscous fiber, and almonds, has been shown to lower ApoB by up to 24% in controlled trials. Even less restrictive plant-forward approaches that include small amounts of animal products can achieve 15-20% reductions in ApoB when properly implemented.

The effectiveness of plant-based diets stems from multiple factors: absence of dietary cholesterol, minimal saturated fat, high fiber content, and the presence of unique plant compounds that actively lower cholesterol production and enhance particle clearance. Understanding your baseline ApoB levels and response to dietary changes helps optimize your plant-based approach.

Low-Carbohydrate Considerations

Low-carbohydrate diets present a complex picture for ApoB management. While these diets often improve triglycerides and HDL cholesterol, their effect on ApoB varies significantly between individuals. Some people experience ApoB reductions due to weight loss and improved insulin sensitivity, while others see increases, particularly on very high-fat ketogenic diets.

The key factor appears to be the quality of fats consumed. Low-carb diets emphasizing unsaturated fats from sources like avocados, nuts, and olive oil tend to maintain or lower ApoB, while those high in saturated fats from butter, coconut oil, and fatty meats often raise it. Regular monitoring becomes especially important when following a low-carb approach to ensure ApoB levels remain in a healthy range.

Specific Foods That Lower ApoB

Beyond overall dietary patterns, certain foods have demonstrated particular effectiveness at lowering ApoB levels. Incorporating these foods strategically can enhance the ApoB-lowering effects of any healthy diet.

  • Oats and Barley: Rich in beta-glucan, a soluble fiber that can reduce ApoB by 5-10% when consumed daily
  • Fatty Fish: Salmon, mackerel, and sardines provide omega-3 fatty acids that reduce VLDL production
  • Nuts: Almonds, walnuts, and pistachios lower ApoB through multiple mechanisms, with studies showing 5-9% reductions
  • Legumes: Beans, lentils, and chickpeas combine protein, fiber, and phytosterols for comprehensive lipid benefits
  • Soy Foods: Tofu, tempeh, and edamame contain proteins that enhance LDL receptor activity
  • Avocados: Provide monounsaturated fats and fiber that improve ApoB particle clearance

The magnitude of ApoB reduction from individual foods is generally modest, but combining multiple beneficial foods creates synergistic effects. For example, a breakfast of steel-cut oats with ground flaxseed and berries, a lunch featuring lentil soup with avocado, and a dinner of grilled salmon with quinoa and vegetables could collectively reduce ApoB by 15-25% over time.

Creating an ApoB-Lowering Meal Plan

Translating dietary principles into practical meal plans requires balancing ApoB-lowering strategies with personal preferences, cultural considerations, and lifestyle factors. Here's a framework for building meals that support optimal ApoB levels while remaining enjoyable and sustainable.

Breakfast Strategies

Start your day with soluble fiber and plant proteins. Options include overnight oats with chia seeds and berries, tofu scramble with vegetables, or whole grain toast with almond butter and sliced apple. Avoid traditional high-saturated fat breakfasts like bacon and eggs cooked in butter, which can spike ApoB production for hours.

Lunch and Dinner Framework

Build meals around vegetables, whole grains, and lean proteins. Aim for half your plate to be non-starchy vegetables, one quarter whole grains or starchy vegetables, and one quarter protein from fish, legumes, or small portions of poultry. Use olive oil or avocado oil for cooking, and include nuts or seeds as garnishes. This template naturally limits saturated fat while maximizing fiber and beneficial fats.

Smart Snacking

Choose snacks that support ApoB management rather than undermine it. Fresh fruit with a small handful of nuts, hummus with vegetables, or edamame provide fiber and plant proteins. Avoid processed snacks high in trans fats or saturated fats, which can significantly raise ApoB even in small portions.

Monitoring Your Progress

Dietary changes typically begin affecting ApoB levels within 2-4 weeks, with maximum effects seen after 2-3 months of consistent adherence. However, individual responses vary based on genetics, baseline levels, and the specific changes implemented. Regular testing helps you understand your personal response and adjust your approach accordingly.

When monitoring ApoB, it's important to test under consistent conditions - ideally fasted for 12 hours and at the same time of day. Small fluctuations are normal, but trends over time provide the most valuable information. A reduction of 10-20 mg/dL can significantly reduce cardiovascular risk, with optimal levels generally below 80 mg/dL for most adults.

Beyond ApoB itself, monitoring related markers provides a comprehensive picture of your cardiovascular health. Changes in triglycerides, HDL cholesterol, and inflammatory markers like high-sensitivity C-reactive protein often accompany ApoB improvements and indicate broader metabolic benefits from your dietary changes.

When Diet Alone Isn't Enough

While diet can significantly impact ApoB levels, some individuals may not achieve optimal levels through dietary changes alone. Genetic factors, particularly variations in genes like APOB, LDLR, and PCSK9, can result in higher baseline ApoB production or impaired clearance that resists dietary intervention.

If your ApoB remains elevated despite consistent dietary efforts, don't view this as a failure. Instead, consider it valuable information about your individual physiology. Some people require a combination of diet, exercise, weight management, and potentially medication to achieve optimal ApoB levels. The dietary changes remain beneficial even if additional interventions are needed, as they enhance the effectiveness of other treatments and provide numerous health benefits beyond ApoB reduction.

Working with healthcare providers who understand advanced lipid testing and personalized treatment approaches ensures you receive appropriate care. They can help determine whether your elevated ApoB warrants additional intervention based on your overall cardiovascular risk profile, family history, and treatment goals.

Sustaining Long-Term Success

Achieving lasting ApoB reduction requires developing sustainable dietary habits rather than following temporary diets. Focus on gradual changes that you can maintain indefinitely. Start with one or two modifications, such as replacing red meat with fish twice a week or adding a daily serving of oats, then build from there.

Social support enhances long-term adherence. Share your health goals with family and friends, and seek out communities focused on heart-healthy eating. Many people find that involving their household in dietary changes creates a supportive environment and makes meal planning easier.

Remember that perfection isn't necessary or sustainable. An eating pattern that lowers your ApoB by 15% and that you can follow consistently provides far more benefit than a restrictive approach that achieves 25% reduction but proves impossible to maintain. Regular monitoring helps you stay motivated by demonstrating the tangible benefits of your efforts while allowing for adjustments based on your results and life circumstances.

References

  1. Estruch, R., Ros, E., Salas-Salvadó, J., et al. (2018). Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. New England Journal of Medicine, 378(25), e34.[Link][PubMed][DOI]
  2. Jenkins, D.J., Jones, P.J., Lamarche, B., et al. (2011). Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial. JAMA, 306(8), 831-839.[Link][PubMed][DOI]
  3. Sniderman, A.D., Thanassoulis, G., Glavinovic, T., et al. (2019). Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiology, 4(12), 1287-1295.[Link][PubMed][DOI]
  4. Frikke-Schmidt, R., Nordestgaard, B.G., Stene, M.C., et al. (2008). Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA, 299(21), 2524-2532.[PubMed][DOI]
  5. Mensink, R.P., Zock, P.L., Kester, A.D., & Katan, M.B. (2003). Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. American Journal of Clinical Nutrition, 77(5), 1146-1155.[PubMed][DOI]
  6. Brown, L., Rosner, B., Willett, W.W., & Sacks, F.M. (1999). Cholesterol-lowering effects of dietary fiber: a meta-analysis. American Journal of Clinical Nutrition, 69(1), 30-42.[PubMed][DOI]

Frequently Asked Questions

How can I test my ApoB at home?

You can test your ApoB at home with SiPhox Health's Apob Advanced Cholesterol Panel, which includes ApoB testing along with other key cardiovascular markers. For ongoing monitoring, the Heart & Metabolic Program includes ApoB testing and provides regular tracking of your cardiovascular health.

How much can diet realistically lower ApoB?

Diet modifications can typically reduce ApoB levels by 10-30%, depending on your baseline levels, genetic factors, and the specific dietary changes implemented. The Mediterranean diet and Portfolio diet have shown reductions of 15-24% in clinical studies, while individual responses vary based on adherence and personal physiology.

How long does it take to see ApoB changes from diet?

Initial changes in ApoB can occur within 2-4 weeks of dietary modification, with maximum effects typically seen after 2-3 months of consistent adherence. Regular testing every 3 months helps track your progress and allows for dietary adjustments based on your individual response.

What foods should I avoid to lower ApoB?

To lower ApoB, limit foods high in saturated fats such as fatty cuts of red meat, full-fat dairy products, butter, coconut oil, and processed foods containing trans fats. Also minimize refined carbohydrates and added sugars, which can indirectly raise ApoB by increasing triglyceride production.

Is ApoB more important than LDL cholesterol?

Many cardiovascular experts consider ApoB a superior predictor of heart disease risk compared to LDL cholesterol because it directly measures the number of atherogenic particles rather than just their cholesterol content. Studies show ApoB more accurately predicts cardiovascular events, especially in people with metabolic syndrome or diabetes.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details